Create a chip that drugs administered in the brain
Create a chip that controls the brain and administer drugs - A US research team has designed a new chip which, when introduced into the brain, can record neuronal activity in situ and release drugs if you need them.
So far it has been tested experimentally in vivo in rats but it opens a world of possibilities for treatment of neurodegenerative diseases such as Parkinson’s, the Alzheimer's or epilepsy get benefits here
Currently, in the world of neuron medicine, manufactured using silicon microelectrodes; these implants have certain side effects, which, says the researcher from USA" has limited the final expansion of this technique for the development of brain-machine interfaces.
" This new device is flexible and biocompatible and being fabricated on a polymer SU-8, to integrate microscopic recording of neuronal activity with the drug application. And, as explained explains CSIC researcher at the USA, scientific coordinator of the project, "In many cases, the detection of epilepsy, Parkinson's and Alzheimer's can only be done through semi-chronic implanted electrodes in the brain as patients.
Technologies used for this purpose must be therefore, the least invasive as possible and ensure a biocompatible, and the integrity of neuronal circuits adjacent to the implant.
“This innovation in health has been published in the journal Lab on a Chip technology and is a step very important in creating devices that interact with the brain at microscopic scales.
In fact, the technological development has been the main integrating electrodes at the same level as the surface of the polymer. Subsequently explained researcher "Integration of the fluidic channels was performed using lithographic techniques and development of a system that ensures the registration package and the simultaneous release of the drugs;”alternative solutions
So far it has been tested in vivo experiments in rats. The next step in development is to test the new devices in user testing to prototype oriented biomedicine. The team currently is looking for companies interested in the patent for viability once analyzed, making this technology on a large scale.
Create a chip that controls the brain and administer drugs - A US research team has designed a new chip which, when introduced into the brain, can record neuronal activity in situ and release drugs if you need them.
So far it has been tested experimentally in vivo in rats but it opens a world of possibilities for treatment of neurodegenerative diseases such as Parkinson’s, the Alzheimer's or epilepsy get benefits here
Currently, in the world of neuron medicine, manufactured using silicon microelectrodes; these implants have certain side effects, which, says the researcher from USA" has limited the final expansion of this technique for the development of brain-machine interfaces.
" This new device is flexible and biocompatible and being fabricated on a polymer SU-8, to integrate microscopic recording of neuronal activity with the drug application. And, as explained explains CSIC researcher at the USA, scientific coordinator of the project, "In many cases, the detection of epilepsy, Parkinson's and Alzheimer's can only be done through semi-chronic implanted electrodes in the brain as patients.
Technologies used for this purpose must be therefore, the least invasive as possible and ensure a biocompatible, and the integrity of neuronal circuits adjacent to the implant.
“This innovation in health has been published in the journal Lab on a Chip technology and is a step very important in creating devices that interact with the brain at microscopic scales.
In fact, the technological development has been the main integrating electrodes at the same level as the surface of the polymer. Subsequently explained researcher "Integration of the fluidic channels was performed using lithographic techniques and development of a system that ensures the registration package and the simultaneous release of the drugs;”alternative solutions
So far it has been tested in vivo experiments in rats. The next step in development is to test the new devices in user testing to prototype oriented biomedicine. The team currently is looking for companies interested in the patent for viability once analyzed, making this technology on a large scale.
No comments:
Post a Comment